enap tablets
krka d.d. - enalapril (enalapril maleate) - tablets - 20mg
enap tablets
krka d.d. - enalapril (enalapril maleate) - tablets - 10mg
ena-denk 10 tablets
denk pharma gmbh & co. kg - enalapril (enalapril maleate) - tablets - 10mg
ena-denk 20 tablets
denk pharma gmbh & co. kg - enalapril (enalapril maleate) - tablets - 20mg
vasotop 0.625 mg tablets
intervet uk ltd - ramipril -
vasotop 10 mg tablets
intervet uk ltd - ramipril -
zofenil 30 mg film-coated tablet
menarini international operations luxembourg s.a. - zofenopril calcium - film-coated tablet - 30 milligram(s) - ace inhibitors, plain; zofenopril
zofenil 7.5 mg film-coated tablets
menarini international operations luxembourg s.a. - zofenopril calcium - film-coated tablet - 7.5 milligram(s) - ace inhibitors, plain; zofenopril
odrik 0.5mg hard capsules
mylan ire healthcare limited - trandolapril - capsule, hard - 0.5 milligram(s) - ace inhibitors, plain; trandolapril - ace inhibitors, plain - all grades of essential hypertension; improves survival following myocardial infarction in patients with left ventricular dysfunction (ejection fraction 35 percent), with or without symptoms of heart failure and/or with or without residual ischaemia; reduces significantly the overall mortality, especially from cardiovascular mortality. it significantly decreases the risk of sudden death and the occurrence of severe or resistant heart failure, and tends to decrease the incidence of fatal and non-fatal reinfarctions.
odrik 1mg hard capsules
mylan ire healthcare limited - trandolapril - capsule, hard - 1.0 milligram(s) - ace inhibitors, plain; trandolapril - ace inhibitors, plain - all grades of essential hypertension; improves survival following myocardial infarction in patients with left ventricular dysfunction (ejection fraction 35 percent), with or without symptoms of heart failure and/or with or without residual ischaemia; reduces significantly the overall mortality, especially from cardiovascular mortality. it significantly decreases the risk of sudden death and the occurrence of severe or resistant heart failure, and tends to decrease the incidence of fatal and non-fatal reinfarctions